SDC1 and plasma cell myeloma: In one-way repeated measures of ANOVA, the sub-IC50 concentration of SAHA used had only a marginal effect on the survival of fresh myeloma cells (CD138+; 80.87% in SAHA treated vs 100% in untreated).